| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 59,529 | 60,930 | 60,942 | 57,742 | | Cost of Revenue | 33,580 | 33,463 | 33,249 | (449) | | | Gross Profit | 25,949 | 27,467 | 27,693 | 58,191 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 8,073 | 8,624 | 9,563 | 41,511 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 15,260 | 14,228 | 14,810 | 14,315 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 2,616 | 4,615 | 3,320 | 2,365 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 233 | (54) | (47) | 344 | | Earnings Before Interest And Taxes | 2,849 | 4,561 | 3,273 | 2,709 | | Interest Expense | 3,046 | 3,046 | 2,310 | 3,281 | | Income Before Tax | (197) | 1,515 | 963 | (572) | | Income Tax Expense | 14 | 616 | 884 | 1,044 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (211) | 899 | 79 | (1,616) | | | Non-recurring Events | | Discontinued Operations |
-
| 60 | 2,439 | (518) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (211) | 959 | 2,518 | (2,134) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($211) | $959 | $2,518 | ($2,134) |
|
0.03% Nasdaq 
Income Statement
